8-KThe WireRoutine
Shareholder Vote
Filed Jun 4, 2026 · 25d ago · Accession 0001213900-26-065294
Plain English
Material event — a significant development the company must disclose promptly.
Read the source below for the full document.
Filing details
- Company
- Oruka Therapeutics, Inc.
- Ticker
- ORKA
- CIK
- 907654
- Form type
- 8-K
- Filing date
- Jun 4, 2026
- Report date
- Jun 2, 2026
- Document
- ea0293648-8k_oruka.htm
- Size
- 192 KB